Issues

Issuer’s debut green bond in the currency lands through euro curve

The capital increase is set to fund a big uranium purchase from Kazatomprom, the world's largest producer

Better to lock in funding now than wait, as spreads set to move higher

Schott Pharma delivered a welcome pop in the aftermarket, gaining more than 11%

The company is strong and has a good ESG profile, but ownership is a question mark

Second benchmark in the currency for the Finnish issuer takes funding to 85%

◆ ALD expands after buying LeasePlan ◆ New deal dwarfs previous issues from either company ◆ Investors show support with €2.8bn of orders

◆ Deteriorating market conditions made worse by investors demanding higher premium ◆ 'Wise' decision to print after two days of calls ◆ Shawbrook sells private placement-like tier two in sterling

Land hits upper end of size target after being 'reasonable' about pricing

Wienerberger makes SLB debut for €350m

Covered bonds, SSAs widen on concerns about rates and Italy's budget deficit

The bank paid only a slim concession, if any